T. Rudiger, D. Weisenburger, and J. Anderson, Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project, Annals of Oncology, vol.13, issue.1, pp.140-149, 2002.
DOI : 10.1093/annonc/mdf033

S. Swerdlow, E. Campo, and N. Harris, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008.

J. Vose, J. Armitage, and D. Weisenburger, International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes, J Clin Oncol, vol.26, pp.4124-4154, 2008.

F. Foss, P. Zinzani, and J. Vose, Peripheral T-cell lymphoma, Blood, vol.117, issue.25, pp.6756-67, 2011.
DOI : 10.1182/blood-2010-05-231548

L. De-leval, B. Bisig, and C. Thielen, Molecular classification of T-cell lymphomas, Critical Reviews in Oncology/Hematology, vol.72, issue.2, pp.125-168, 2009.
DOI : 10.1016/j.critrevonc.2009.01.002

R. Costello, C. Sanchez, L. Treut, and T. , Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations, British Journal of Haematology, vol.102, issue.Suppl. 5, pp.21-28, 2010.
DOI : 10.1111/j.1365-2141.2009.07977.x

L. De-leval, D. Rickman, and C. Thielen, The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells, Blood, vol.109, issue.11, pp.4952-63, 2007.
DOI : 10.1182/blood-2006-10-055145

L. Lamant, A. De-reynies, and M. Duplantier, Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes, Blood, vol.109, issue.5, pp.2156-64, 2007.
DOI : 10.1182/blood-2006-06-028969

M. Thompson, J. Stumph, and S. Henrickson, Differential gene expression in anaplastic lymphoma kinase???positive and anaplastic lymphoma kinase???negative anaplastic large cell lymphomas, Human Pathology, vol.36, issue.5, pp.494-504, 2005.
DOI : 10.1016/j.humpath.2005.03.004

J. Iqbal, D. Weisenburger, and T. Greiner, Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma, Blood, vol.115, issue.5, pp.1026-1062, 2010.
DOI : 10.1182/blood-2009-06-227579

Y. Huang, A. De-reynies, and L. De-leval, Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type, Blood, vol.115, issue.6, pp.1226-1263, 2010.
DOI : 10.1182/blood-2009-05-221275
URL : https://hal.archives-ouvertes.fr/inserm-00462629

B. Martinez-delgado, M. Cuadros, and E. Honrado, Differential expression of NF-??B pathway genes among peripheral T-cell lymphomas, Leukemia, vol.100, issue.12, pp.2254-63, 2005.
DOI : 10.1073/pnas.95.5.2307

B. Ballester, O. Ramuz, and C. Gisselbrecht, Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas, Oncogene, vol.89, issue.10, pp.1560-70, 2006.
DOI : 10.1186/gb-2003-4-4-r28

M. Cuadros, S. Dave, and E. Jaffe, Identification of a Proliferation Signature Related to Survival in Nodal Peripheral T-Cell Lymphomas, Journal of Clinical Oncology, vol.25, issue.22, pp.3321-3330, 2007.
DOI : 10.1200/JCO.2006.09.4474

P. Piccaluga, C. Agostinelli, and P. Zinzani, Expression of platelet-derived growth factor receptor ?? in peripheral T-cell lymphoma not otherwise specified, The Lancet Oncology, vol.6, issue.6, p.440, 2005.
DOI : 10.1016/S1470-2045(05)70213-8

P. Piccaluga, C. Agostinelli, and A. Califano, Gene Expression Analysis of Angioimmunoblastic Lymphoma Indicates Derivation from T Follicular Helper Cells and Vascular Endothelial Growth Factor Deregulation, Cancer Research, vol.67, issue.22, pp.10703-10713, 2007.
DOI : 10.1158/0008-5472.CAN-07-1708

P. Piccaluga, C. Agostinelli, and A. Califano, Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets, Journal of Clinical Investigation, vol.117, issue.3, pp.823-857, 2007.
DOI : 10.1172/JCI26833DS1

S. Ng, V. Selvarajan, and G. Huang, Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling, The Journal of Pathology, vol.35, issue.Suppl 2, pp.496-510, 2011.
DOI : 10.1002/path.2823

B. Streubel, U. Vinatzer, and M. Willheim, Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma, Leukemia, vol.99, issue.2, pp.313-321, 2006.
DOI : 10.1038/sj.leu.2404045

A. Feldman, M. Law, and E. Remstein, Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas, Leukemia, vol.19, issue.3, pp.574-80, 2009.
DOI : 10.1182/blood-2004-07-2911

A. Feldman, A. Dogan, and D. Smith, Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing, Blood, vol.117, issue.3, pp.915-924, 2011.
DOI : 10.1182/blood-2010-08-303305

J. Morris, T. Waldmann, and J. Janik, Receptor-Directed Therapy of T-Cell Leukemias and Lymphomas, Journal of Immunotoxicology, vol.102, issue.1, pp.235-283, 2008.
DOI : 10.1080/07357900701360096

K. Dunleavy, R. Piekarz, and J. Zain, New Strategies in Peripheral T-Cell Lymphoma: Understanding Tumor Biology and Developing Novel Therapies, Clinical Cancer Research, vol.16, issue.23, pp.5608-5625, 2010.
DOI : 10.1158/1078-0432.CCR-09-1995

L. De-leval and P. Gaulard, Pathobiology and Molecular Profiling of Peripheral T-Cell Lymphomas, Hematology, vol.2008, issue.1, pp.272-281, 2008.
DOI : 10.1182/asheducation-2008.1.272

L. De-leval and P. Gaulard, Pathology and biology of peripheral T-cell lymphomas, Histopathology, vol.6, issue.1, pp.49-68, 2011.
DOI : 10.1111/j.1365-2559.2010.03704.x

P. Piccaluga, C. Agostinelli, and C. Tripodo, Peripheral T-cell lymphoma classification: the matter of cellular derivation, Expert Review of Hematology, vol.4, issue.4, pp.415-440, 2011.
DOI : 10.1586/ehm.11.37

P. Gaulard, K. Belhadj, and R. F. Gammadelta, ????T-cell lymphomas, Seminars in Hematology, vol.40, issue.3, pp.233-276, 2003.
DOI : 10.1016/S0037-1963(03)00137-9

C. Tripodo, E. Iannitto, and A. Florena, Gamma-delta T-cell lymphomas, Nature Reviews Clinical Oncology, vol.18, issue.12, pp.707-724, 2009.
DOI : 10.1038/nrclinonc.2009.169

W. Macon, N. Levy, and P. Kurtin, Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas

K. Belhadj, F. Reyes, and J. Farcet, Hepatosplenic ???? T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients, Blood, vol.102, issue.13, pp.4261-4270, 2003.
DOI : 10.1182/blood-2003-05-1675

F. Vega, L. Medeiros, and P. Gaulard, Hepatosplenic and Other ???? T-Cell Lymphomas, American Journal of Clinical Pathology, vol.127, issue.6, pp.869-80, 2007.
DOI : 10.1309/LRKX8CE7GVPCR1FT

J. Toro, D. Liewehr, and N. Pabby, Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma, Blood, vol.101, issue.9, pp.3407-3419, 2003.
DOI : 10.1182/blood-2002-05-1597

R. Willemze, E. Jaffe, and G. Burg, WHO-EORTC classification for cutaneous lymphomas, Blood, vol.105, issue.10, pp.3768-85, 2005.
DOI : 10.1182/blood-2004-09-3502

B. Arnulf, C. Copie-bergman, and M. Delfau-larue, Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization, Blood, vol.91, pp.1723-1754, 1998.

K. Miyazaki, M. Yamaguchi, and H. Imai, Gene expression profiling of peripheral T-cell lymphoma including ???? T-cell lymphoma, Blood, vol.113, issue.5, pp.1071-1075, 2009.
DOI : 10.1182/blood-2008-07-166363

J. Iqbal, D. Weisenburger, and A. Chowdhury, Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic ???? T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro, Leukemia, vol.25, issue.8, p.1377, 2011.
DOI : 10.1038/leu.2011.102

A. Garcia-herrera, J. Song, and S. Chuang, Nonhepatosplenic ???? T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation, The American Journal of Surgical Pathology, vol.35, issue.8, pp.1214-1239, 2011.
DOI : 10.1097/PAS.0b013e31822067d1

M. Roullet, S. Gheith, and J. Mauger, Percentage of ???? T Cells in Panniculitis by Paraffin Immunohistochemical Analysis, American Journal of Clinical Pathology, vol.131, issue.6, pp.820-826, 2009.
DOI : 10.1309/AJCPMG37MXKYPUBE

W. Morice, The Immunophenotypic Attributes of NK Cells and NK-Cell Lineage Lymphoproliferative Disorders, American Journal of Clinical Pathology, vol.127, issue.6, pp.881-887, 2007.
DOI : 10.1309/Q49CRJ030L22MHLF

W. Morice, D. Jevremovic, and H. Olteanu, Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets, Leukemia, vol.178, issue.4, pp.881-885, 2010.
DOI : 10.1046/j.1365-2141.1997.3623176.x

W. Haedicke, F. Ho, and A. Chott, Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas, Blood, vol.95, pp.3628-3658, 2000.

W. Morice, W. Macon, and A. Dogan, NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis, Leukemia, vol.95, issue.5, pp.883-889, 2006.
DOI : 10.1016/S1074-7613(01)00168-6

D. Dukers, M. Vermeer, and L. Jaspars, Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype, Journal of Clinical Pathology, vol.54, issue.3, pp.224-232, 2001.
DOI : 10.1136/jcp.54.3.224

E. Poszepczynska-guigne, V. Schiavon, D. Incan, and M. , CD158k/KIR3DL2 Is a New Phenotypic Marker of Sezary Cells: Relevance for the Diagnosis and Follow-Up of Sezary Syndrome, Journal of Investigative Dermatology, vol.122, issue.3, pp.820-823, 2004.
DOI : 10.1111/j.0022-202X.2004.22326.x

D. Bahler, L. Hartung, and S. Hill, CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in S??zary syndrome by flow cytometry, Cytometry Part B: Clinical Cytometry, vol.4, issue.3, pp.156-62, 2008.
DOI : 10.1002/cyto.b.20395

N. Asano, R. Suzuki, and Y. Kagami, Clinicopathologic and Prognostic Significance of Cytotoxic Molecule Expression in Nodal Peripheral T-Cell Lymphoma, Unspecified, The American Journal of Surgical Pathology, vol.29, issue.10, pp.1284-93, 2005.
DOI : 10.1097/01.pas.0000173238.17331.6b

N. Asano, R. Suzuki, and K. Ohshima, Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma, International Journal of Hematology, vol.4, issue.3, pp.426-461, 2010.
DOI : 10.1007/s12185-010-0513-0

P. Kanavaros, M. Boulland, and B. Petit, Expression of Cytotoxic Proteins in Peripheral T-Cell and Natural Killer-Cell (NK) Lymphomas: Association with Extranodal Site, NK or T???? Phenotype, Anaplastic Morphology and CD30 Expression, Leukemia & Lymphoma, vol.148, issue.3-4, pp.317-343, 2000.
DOI : 10.1046/j.1365-2559.1999.00582.x

C. Vinuesa, S. Tangye, B. Moser, and C. Mackay, Follicular B helper T cells in antibody responses and autoimmunity, Nature Reviews Immunology, vol.84, issue.11, pp.853-65, 2005.
DOI : 10.1002/eji.200425442

S. Crotty, ), Annual Review of Immunology, vol.29, issue.1, pp.621-63, 2011.
DOI : 10.1146/annurev-immunol-031210-101400

T. Chtanova, S. Tangye, and R. Newton, T Follicular Helper Cells Express a Distinctive Transcriptional Profile, Reflecting Their Role as Non-Th1/Th2 Effector Cells That Provide Help for B Cells, The Journal of Immunology, vol.173, issue.1, pp.68-78, 2004.
DOI : 10.4049/jimmunol.173.1.68

C. Kim, H. Lim, and J. Kim, Unique gene expression program of human germinal center T helper cells, Blood, vol.104, issue.7, pp.1952-60, 2004.
DOI : 10.1182/blood-2004-03-1206

L. De-leval, C. Gisselbrecht, and P. Gaulard, Advances in the understanding and management of angioimmunoblastic T-cell lymphoma, British Journal of Haematology, vol.9, issue.Suppl. 2, pp.673-89, 2010.
DOI : 10.1111/j.1365-2141.2009.08003.x

K. Grogg, A. Attygalle, and W. Macon, Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?, Blood, vol.106, issue.4, pp.1501-1503, 2005.
DOI : 10.1182/blood-2005-03-1083

J. Dupuis, K. Boye, and N. Martin, Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL), The American Journal of Surgical Pathology, vol.30, issue.4, pp.490-494, 2006.
DOI : 10.1097/00000478-200604000-00009

H. Yu, A. Shahsafaei, and D. Dorfman, Germinal-Center T-Helper-Cell Markers PD-1 and CXCL13 Are Both Expressed by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma, American Journal of Clinical Pathology, vol.131, issue.1
DOI : 10.1309/AJCP62WRKERPXDRT

D. Dorfman, J. Brown, A. Shahsafaei, and G. Freeman, Programmed Death-1 (PD-1) is a Marker of Germinal Center-associated T Cells and Angioimmunoblastic T-Cell Lymphoma, The American Journal of Surgical Pathology, vol.30, issue.7, pp.802-812, 2006.
DOI : 10.1097/01.pas.0000209855.28282.ce

T. Marafioti, J. Paterson, and E. Ballabio, The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation, Haematologica, vol.95, issue.3, pp.432-441, 2010.
DOI : 10.3324/haematol.2009.010991
URL : https://hal.archives-ouvertes.fr/inserm-00477518

D. Dorfman and A. Shahsafaei, CD200 (OX-2 Membrane Glycoprotein) is Expressed by Follicular T Helper Cells and in Angioimmunoblastic T-cell Lymphoma, The American Journal of Surgical Pathology, vol.35, issue.1, pp.76-83, 2011.
DOI : 10.1097/PAS.0b013e31820065c9

G. Roncador, G. Verdes-montenegro, J. Tedoldi, and S. , Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma, Haematologica, vol.92, issue.8, pp.1059-66, 2007.
DOI : 10.3324/haematol.10864

H. Ree, M. Kadin, and M. Kikuchi, Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: Heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma, Human Pathology, vol.30, issue.4, pp.403-414, 1999.
DOI : 10.1016/S0046-8177(99)90115-6

B. Bisig, C. Thielen, and C. Herens, c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis, Histopathology, vol.132, issue.2, 2011.
DOI : 10.1111/j.1365-2559.2011.04022.x

S. Rodriguez-pinilla, L. Atienza, and C. Murillo, Peripheral T-cell Lymphoma With Follicular T-cell Markers, The American Journal of Surgical Pathology, vol.32, issue.12, pp.1787-99, 2008.
DOI : 10.1097/PAS.0b013e31817f123e

H. Zhan, X. Li, and X. Zhu, Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases, Journal of Clinical Pathology, vol.64, issue.4, pp.319-343, 2011.
DOI : 10.1136/jcp.2010.084459

P. Gaulard and L. De-leval, Follicular helper T cells: implications in neoplastic hematopathology, Seminars in Diagnostic Pathology, vol.28, issue.3, pp.202-215, 2011.
DOI : 10.1053/j.semdp.2011.03.003
URL : https://hal.archives-ouvertes.fr/inserm-00616864

L. De-leval, E. Savilo, and J. Longtine, Peripheral T-Cell Lymphoma With Follicular Involvement and a CD4+/bcl-6+ Phenotype, The American Journal of Surgical Pathology, vol.25, issue.3, pp.395-400, 2001.
DOI : 10.1097/00000478-200103000-00015

Y. Huang, A. Moreau, and J. Dupuis, Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas, The American Journal of Surgical Pathology, vol.33, issue.5, pp.682-90, 2009.
DOI : 10.1097/PAS.0b013e3181971591
URL : https://hal.archives-ouvertes.fr/inserm-00385332

R. Pinilla, S. Roncador, G. Rodriguez-peralto, and J. , Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers, The American Journal of Surgical Pathology, vol.33, issue.1, pp.81-90, 2009.
DOI : 10.1097/PAS.0b013e31818e52fe

H. Beltraminelli, B. Leinweber, H. Kerl, and L. Cerroni, Primary Cutaneous CD4+ Small-/Medium-Sized Pleomorphic T-Cell Lymphoma: A Cutaneous Nodular Proliferation of Pleomorphic T Lymphocytes of Undetermined Significance? A Study of 136 Cases, The American Journal of Dermatopathology, vol.31, issue.4, pp.317-339, 2009.
DOI : 10.1097/DAD.0b013e31819f19bb

A. Al-shamkhani, The role of CD30 in the pathogenesis of haematopoietic malignancies, Current Opinion in Pharmacology, vol.4, issue.4, pp.355-364, 2004.
DOI : 10.1016/j.coph.2004.02.007

L. De-leval and P. Gaulard, CD30+ lymphoproliferative disorders, Haematologica, vol.95, issue.10, pp.1627-1657, 2010.
DOI : 10.3324/haematol.2010.029256

K. Savage, N. Harris, and J. Vose, ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project, Blood, vol.111, issue.12, pp.5496-504, 2008.
DOI : 10.1182/blood-2008-01-134270

J. Francisco, C. Cerveny, and D. Meyer, cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity, Blood, vol.102, issue.4, pp.1458-65, 2003.
DOI : 10.1182/blood-2003-01-0039

K. Foyil and N. Bartlett, lymphomas, Immunotherapy, vol.3, issue.4, pp.475-85, 2011.
DOI : 10.2217/imt.11.15

S. Ansell, Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cells, Expert Opinion on Investigational Drugs, vol.62, issue.1, pp.99-105, 2011.
DOI : 10.1056/NEJMoa1002965

S. Rodig, J. Abramson, and G. Pinkus, Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H), Clinical Cancer Research, vol.12, issue.23, pp.7174-7183, 2006.
DOI : 10.1158/1078-0432.CCR-06-1275

C. Dearden and E. Matutes, Alemtuzumab in T-cell lymphoproliferative disorders, Best Practice & Research Clinical Haematology, vol.19, issue.4, pp.795-810, 2006.
DOI : 10.1016/j.beha.2006.05.005

R. Howman and H. Prince, New drug therapies in peripheral T-cell lymphoma, Expert Review of Anticancer Therapy, vol.11, issue.3, pp.457-72, 2011.
DOI : 10.1586/era.11.4

P. Piccaluga, C. Agostinelli, and S. Righi, Expression of CD52 in peripheral T-cell lymphoma, Haematologica, vol.92, issue.4, pp.566-573, 2007.
DOI : 10.3324/haematol.10767

S. Chang, C. Lu, and S. Chuang, CD52 expression in non-mycotic T- and NK/T-cell lymphomas, Leukemia & Lymphoma, vol.7, issue.1, pp.117-138, 2007.
DOI : 10.3816/CLM.2000.n.002

E. Geissinger, I. Bonzheim, and S. Roth, CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies, Leukemia & Lymphoma, vol.16, issue.6, pp.1010-1016, 2009.
DOI : 10.1111/j.1365-2141.2009.07606.x

L. Jiang, C. Yuan, and J. Hubacheck, Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy, British Journal of Haematology, vol.63, issue.Suppl., pp.173-182, 2009.
DOI : 10.1111/j.1365-2141.2009.07606.x

L. Ginaldi, D. Martinis, M. Matutes, and E. , Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H, Leukemia Research, vol.22, issue.2, pp.185-91, 1998.
DOI : 10.1016/S0145-2126(97)00158-6

A. Gallamini, F. Zaja, and C. Patti, Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial, Blood, vol.110, issue.7, pp.2316-2339, 2007.
DOI : 10.1182/blood-2007-02-074641

H. Amin and R. Lai, Pathobiology of ALK+ anaplastic large-cell lymphoma, Blood, vol.110, issue.7, pp.2259-67, 2007.
DOI : 10.1182/blood-2007-04-060715

T. Webb, J. Slavish, and R. George, Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy, Expert Review of Anticancer Therapy, vol.9, issue.3, pp.331-56, 2009.
DOI : 10.1586/14737140.9.3.331

B. Falini, K. Pulford, and A. Pucciarini, Lymphomas expressing ALK fusion protein(s) other than NPM-ALK, Blood, vol.94, pp.3509-3524, 1999.

D. Gerber and J. Minna, ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time, Cancer Cell, vol.18, issue.6, pp.548-51, 2010.
DOI : 10.1016/j.ccr.2010.11.033

A. Andreotti, P. Schwartzberg, R. Joseph, and L. Berg, T-Cell Signaling Regulated by the Tec Family Kinase, Itk, Cold Spring Harbor Perspectives in Biology, vol.2, issue.7, p.2287, 2010.
DOI : 10.1101/cshperspect.a002287

M. Turner, E. Schweighoffer, and F. Colucci, Tyrosine kinase SYK: essential functions for immunoreceptor signalling, Immunology Today, vol.21, issue.3, pp.148-54, 2000.
DOI : 10.1016/S0167-5699(99)01574-1

S. Rigby, Y. Huang, and B. Streubel, The Lymphoma-associated Fusion Tyrosine Kinase ITK-SYK Requires Pleckstrin Homology Domain-mediated Membrane Localization for Activation and Cellular Transformation, Journal of Biological Chemistry, vol.284, issue.39, pp.26871-81, 2009.
DOI : 10.1074/jbc.M109.034272

K. Pechloff, J. Holch, and U. Ferch, The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma, The Journal of Experimental Medicine, vol.86, issue.5, pp.1031-1075, 2010.
DOI : 10.1002/art.23992

C. Dierks, F. Adrian, and P. Fisch, The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease, Cancer Research, vol.70, issue.15, pp.6193-204, 2010.
DOI : 10.1158/0008-5472.CAN-08-3719

A. Feldman, D. Sun, and M. Law, Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas, Leukemia, vol.103, issue.6, pp.1139-1182, 2008.
DOI : 10.1038/leu.2008.77

R. Wilcox, D. Sun, and A. Novak, Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines, Leukemia, vol.181, issue.1, pp.229-261, 2010.
DOI : 10.1158/0008-5472.CAN-07-0331

D. Wada, M. Law, and E. Hsi, Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies, Modern Pathology, vol.91, issue.4, pp.596-605, 2011.
DOI : 10.1038/nature07064

A. Pham-ledard, M. Prochazkova-carlotti, and E. Laharanne, IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases, Journal of Investigative Dermatology, vol.130, issue.3, pp.816-841, 2010.
DOI : 10.1038/jid.2009.314

G. Gualco, L. Weiss, and C. Bacchi, MUM1/IRF4, Applied Immunohistochemistry & Molecular Morphology, vol.18, issue.4, pp.301-311, 2010.
DOI : 10.1097/PAI.0b013e3181cf1126

W. Zhao, Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways, Leukemia, vol.32, issue.1, pp.13-21, 2010.
DOI : 10.1016/j.cellsig.2009.03.009

P. Jost and J. Ruland, Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications, Blood, vol.109, pp.2700-2707, 2007.

R. Horie, B in Pathogenesis and Treatment of Adult T-Cell Leukemia/Lymphoma, International Reviews of Immunology, vol.69, issue.2, pp.269-81, 2007.
DOI : 10.1207/s15327914nc5202_9

K. Izban, M. Ergin, and J. Qin, Constitutive expression of NF-??B is a characteristic feature of mycosis fungoides: Implications for apoptosis resistance and pathogenesis, Human Pathology, vol.31, issue.12, pp.1482-90, 2000.
DOI : 10.1053/hupa.2000.20370

A. Mocsai, J. Ruland, and V. Tybulewicz, The SYK tyrosine kinase: a crucial player in diverse biological functions, Nature Reviews Immunology, vol.28, issue.6, pp.387-402, 2010.
DOI : 10.1038/nri2765

M. Pozzobon, T. Marafioti, and M. Hansmann, Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples, British Journal of Haematology, vol.5, issue.4, pp.519-552, 2004.
DOI : 10.1016/S1074-7613(00)80606-8

E. Geissinger, P. Sadler, and S. Roth, Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations, Haematologica, vol.95, issue.10, pp.1697-704, 2010.
DOI : 10.3324/haematol.2009.021428

J. Andrae, R. Gallini, and C. Betsholtz, Role of platelet-derived growth factors in physiology and medicine, Genes & Development, vol.22, issue.10, pp.1276-312, 2008.
DOI : 10.1101/gad.1653708

Y. Chen, K. Chang, W. Su, and T. Chen, The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas, Annals of Hematology, vol.1, issue.12, pp.985-90, 2008.
DOI : 10.1007/s00277-008-0539-z